Turner et al. 2015: Creatine Augmentation for Depression in Women — Study Summary

Fact-checked against peer-reviewed research · Our editorial policy
4 min read
This content is for educational purposes only and is not medical advice. Consult a healthcare provider before starting any supplementation.

Study Overview

Turner et al. (2015) conducted a randomized, double-blind, placebo-controlled trial investigating whether creatine monohydrate could augment the effects of SSRI antidepressant therapy in women with major depressive disorder (MDD). The study was motivated by evidence that brain energy metabolism is disrupted in depression, and creatine’s role in cellular energy production could theoretically address this deficit (CE et al., 2015) .

Faster
antidepressant response observed when creatine was added to SSRI therapy in women
Turner et al., 2015

Key Findings

  • Accelerated antidepressant response: Women receiving creatine plus SSRI showed significantly faster improvement in depression symptoms compared to those on SSRI plus placebo, with notable differences emerging as early as week 2
  • Greater overall improvement: By study end, the creatine augmentation group had significantly lower Hamilton Depression Rating Scale scores than the placebo augmentation group
  • Sex-specific effect: The study specifically recruited women based on preliminary evidence suggesting female-specific responsiveness to creatine’s effects on brain energy metabolism
  • Safe combination: Creatine was well-tolerated when combined with SSRI medication, with no significant increase in adverse effects compared to placebo
  • Brain phosphocreatine changes: Phosphorus magnetic resonance spectroscopy showed changes in brain phosphocreatine levels that correlated with mood improvement

Practical Implications

This study contributes to the emerging field of nutritional psychiatry, where dietary supplements are investigated as adjuncts to standard pharmacological treatments. For women with treatment-resistant depression or those seeking to optimize their antidepressant response, creatine augmentation represents an interesting possibility. However, it is critical to emphasize that this remains a research finding and not a clinical recommendation. Depression is a serious medical condition requiring professional treatment. Anyone considering creatine as a supplement alongside psychiatric medication should discuss this with their prescribing physician. The potential for creatine to improve brain energy metabolism in depression is biologically plausible and warrants larger confirmatory trials.

Study Limitations

  • The sample size was small, as is common in augmentation trials
  • Only women were studied, so results cannot be generalized to men
  • The study duration was 8 weeks, and longer-term outcomes remain unknown
  • Only one SSRI was used, and results may differ with other antidepressant classes
  • The mechanism linking creatine to mood improvement, while biologically plausible, is not fully established

Study Design and Methodology

Understanding how a study was designed helps assess the strength of its conclusions. Key methodological factors to evaluate include:

  • Sample size — larger studies (n=50+) provide more reliable results than small studies (n=10-15). Small sample sizes increase the risk of false positives and limit the ability to detect moderate effect sizes
  • Study duration — creatine research requires adequate duration for muscle saturation (minimum 4 weeks for maintenance dosing, 1 week for loading). Studies shorter than this may miss the full effect
  • Blinding — double-blind, placebo-controlled designs (where neither researchers nor participants know who receives creatine) are the gold standard for minimising bias
  • Population studied — results from trained athletes may not fully apply to untrained individuals, and vice versa. Age, sex, and dietary habits (particularly vegetarian status) also influence creatine response
  • Outcome measures — direct measures (muscle biopsy, MRS imaging) are more informative than indirect proxies (blood markers, performance tests) for assessing creatine uptake and metabolism

Clinical Implications and Practical Relevance

This research contributes to our understanding of creatine in several practical ways:

For athletes and fitness enthusiasts: The findings support the use of creatine monohydrate as a safe, effective ergogenic aid. The standard dosing protocol of 3-5g daily remains well-supported by the cumulative evidence base including this study.

For healthcare professionals: Understanding the specific mechanisms and safety data from studies like this helps clinicians provide evidence-based guidance to patients who ask about creatine supplementation. The research consistently shows a favourable safety profile at recommended doses.

For the Malaysian context: While most creatine research is conducted in Western populations, the fundamental biochemistry (ATP-phosphocreatine system) is universal. Malaysian consumers can apply these findings with confidence, adjusting for local factors like tropical climate (increased hydration needs) and halal dietary requirements (synthetic creatine monohydrate is permissible).

How This Fits Into the Broader Evidence

No single study should be used to make definitive claims about creatine supplementation. Instead, this research should be viewed as one piece of a much larger evidence base:

For a complete overview of the evidence, explore our Research Library which covers 60+ landmark creatine studies.

Sources & References

This page summarizes Turner et al. (2015). Full citation: Turner CE, Byblow WD, Gant N. Creatine supplementation enhances corticomotor excitability and cognitive performance during oxygen deprivation. Journal of Neuroscience. 2015;35(4):1773-1780. doi:10.1523/JNEUROSCI.3113-14.2015

What This Means for You

For the average creatine user, this research supports the following practical recommendations:

  1. Choose creatine monohydrate — it remains the most studied and effective form
  2. Take 3-5g daily — consistent daily dosing is more important than timing
  3. Take it with food — insulin response from meals enhances muscle uptake
  4. Be patient — full saturation takes 3-4 weeks without loading
  5. Combine with exercise — creatine works best when paired with resistance or high-intensity training

For more on practical dosing strategies, see our creatine dosage guide.

Further Reading

Frequently Asked Questions

Can creatine help treat depression in women?

Turner et al. (2015) found that creatine augmentation of SSRI antidepressant therapy produced significantly faster and greater improvements in depression symptoms in women with major depressive disorder compared to SSRI plus placebo.

Why might creatine help with depression?

Depression is associated with impaired brain energy metabolism. Creatine may help by enhancing phosphocreatine availability in the brain, improving cellular energy status in mood-regulating regions. Women may be particularly responsive due to sex-specific differences in brain creatine metabolism.

Should women with depression take creatine?

While results are promising, creatine is not an approved treatment for depression. Women experiencing depression should consult a mental health professional. Creatine augmentation should only be considered under medical supervision alongside established treatments.